FDA label
What is Eylea used for?
Eylea contains aflibercept. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Eylea lists 5 uses: Neovascular (Wet) Age-Related Macular Degeneration (AMD); Macular Edema Following Retinal Vein Occlusion (RVO); Diabetic Macular Edema (DME); Diabetic Retinopathy (DR); and 1 more.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Eylea?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Eylea, injection, solution
Indications and Usage, quoted from the label by Regeneron Pharmaceuticals, Inc. (BLA125387). Cross-references to other label sections are left out.
EYLEA is indicated for the treatment of:
Neovascular (Wet) Age-Related Macular Degeneration (AMD)
Macular Edema Following Retinal Vein Occlusion (RVO)
Diabetic Macular Edema (DME)
Diabetic Retinopathy (DR)
Retinopathy of Prematurity (ROP)
Source: DailyMed label, set id f96cfd69-da34-41ee-90a9-610a4655cd1c, version 41, effective July 7, 2026. NDC 61755-005, one of 1 listing for this product.
Questions
What is Eylea used for?
The FDA label for Eylea lists 5 uses: Neovascular (Wet) Age-Related Macular Degeneration (AMD); Macular Edema Following Retinal Vein Occlusion (RVO); Diabetic Macular Edema (DME); Diabetic Retinopathy (DR); and 1 more.
What drug class is Eylea?
FDA lists aflibercept in the Vascular Endothelial Growth Factor Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.